189 EFFICACY OF TIPS FOR THE PREVENTION OF TOTAL PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS WAITING FOR LIVER TRANSPLANTATION

2012 ◽  
Vol 56 ◽  
pp. S81 ◽  
Author(s):  
D. D'Avola ◽  
J.I. Bilbao ◽  
G. Zozaya ◽  
F. Pardo ◽  
F. Rotellar ◽  
...  
2015 ◽  
Vol 148 (4) ◽  
pp. S-1041
Author(s):  
Waseem Butt ◽  
Vaibhav Agrawal ◽  
Amir Rezk ◽  
Michael Komar ◽  
Robert Smith ◽  
...  

Author(s):  
Cynthia Williams ◽  
Erin Stewart ◽  
Kendra D. Conzen ◽  
Scott Wolf ◽  
Timothy T. Tran

There are limited data to guide the use of anticoagulation in cirrhotic patients prior to liver transplantation especially when using direct oral anticoagulants. In this article, we present 2 cases. The first is a 42-year-old male with cirrhosis complicated by portal vein thrombosis (PVT) treated with dabigatran who underwent orthotopic liver transplantation without complication. The second case is a 65-year-old man with alcoholic cirrhosis complicated by PVT treated with dabigatran who underwent orthotopic liver transplantation and required reoperation for surgical bleeding. Both patients were treated with dabigatran’s reversal agent idarucizumab prior to incision. In this case series, we discuss the treatment of cirrhotic patients with various anticoagulants, considerations for anticoagulant selection and reversal prior to liver transplant, and questions for future investigation.


HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S349
Author(s):  
Hao-Chien Hung ◽  
Jin-Chiao Lee ◽  
Chih-Hsien Cheng ◽  
Tsung-Han Wu ◽  
Chen-Fang Lee ◽  
...  

2021 ◽  
Vol 15 (5) ◽  
Author(s):  
Evgenia Kotsifa ◽  
Stylianos Kykalos ◽  
Nikolaos Machairas ◽  
Nikolaos Nikiteas ◽  
Georgios Sotiropoulos

2018 ◽  
Vol 24 (39) ◽  
pp. 4419-4427 ◽  
Author(s):  
Irina Gîrleanu ◽  
Anca Trifan ◽  
Carol Stanciu ◽  
Cătălin Sfarti

Sign in / Sign up

Export Citation Format

Share Document